IPO5 and Alzheimer disease: Prior work on RANs in AD showed reduced expression of RAN, RANBP1, RANBP2, RANBP5, RANBP9 and RANBP10 in AD tissues, proposing that the toxic forms of APP knocked down RANs and thus reduced import into the nucleus60.